Extrait

A proof-of-concept, dose finding, controlled, single-center, randomized, double-blind, fixed dose phase 2 trial with ZP1848 in patients with Short Bowel Syndrome.

Critère d'inclusion

• Short Bowel Syndrome

Liens

• ictrp
• nct